THE PENNANT GROUP, INC. Interest Expense Nonoperating
THE PENNANT GROUP, INC. (PNTG) reported Interest Expense Nonoperating of $3.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- THE PENNANT GROUP, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $3.35M, a 178.07% increase year-over-year.
- THE PENNANT GROUP, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $3.07M, a 154.61% increase year-over-year.
- THE PENNANT GROUP, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $3.25M, a 400.46% increase year-over-year.
- THE PENNANT GROUP, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $1.02M, a 64.87% decline year-over-year.
- THE PENNANT GROUP, INC. interest expense nonoperating for fiscal 2025 was $6.68M, a 4.00% decline from fiscal 2024.
- THE PENNANT GROUP, INC. interest expense nonoperating for fiscal 2024 was $6.96M, a 17.42% increase from fiscal 2023.
- THE PENNANT GROUP, INC. interest expense nonoperating for fiscal 2023 was $5.92M, a 55.24% increase from fiscal 2022.
- THE PENNANT GROUP, INC. interest expense nonoperating for fiscal 2022 was $3.82M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.35M 10-Q · filed 2026-08-05 | $6.42M 10-Q · filed 2026-08-05 | $9.67M derived: sum of 3 quarters · filed 2026-08-05 | $10.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.07M 10-Q · filed 2026-05-06 | $6.32M derived: sum of 2 quarters · filed 2026-05-06 | $7.34M derived: sum of 3 quarters · filed 2026-05-06 | $8.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.27M derived: sum of 2 quarters · filed 2026-02-26 | $5.47M derived: sum of 3 quarters · filed 2026-08-05 | $6.68M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.02M 10-Q · filed 2025-11-05 | $2.22M derived: sum of 2 quarters · filed 2026-08-05 | $3.42M 10-Q · filed 2025-11-05 | $4.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.20M 10-Q · filed 2026-08-05 | $2.41M 10-Q · filed 2026-08-05 | $3.06M derived: sum of 3 quarters · filed 2026-08-05 | $5.95M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.21M 10-Q · filed 2026-05-06 | $1.85M derived: sum of 2 quarters · filed 2026-05-06 | $4.75M derived: sum of 3 quarters · filed 2026-05-06 | $6.37M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.54M derived: sum of 2 quarters · filed 2026-02-26 | $5.16M derived: sum of 3 quarters · filed 2026-02-26 | $6.96M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.89M 10-Q · filed 2025-11-05 | $4.51M derived: sum of 2 quarters · filed 2025-11-05 | $6.31M 10-Q · filed 2025-11-05 | $7.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.62M 10-Q · filed 2025-08-06 | $3.41M 10-Q · filed 2025-08-06 | $4.98M derived: sum of 3 quarters · filed 2026-02-26 | $6.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.79M 10-Q · filed 2025-05-06 | $3.36M derived: sum of 2 quarters · filed 2026-02-26 | $4.86M derived: sum of 3 quarters · filed 2026-02-26 | $6.31M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.06M derived: sum of 2 quarters · filed 2026-02-26 | $4.52M derived: sum of 3 quarters · filed 2026-02-26 | $5.92M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.50M 10-Q · filed 2024-11-06 | $2.95M derived: sum of 2 quarters · filed 2024-11-06 | $4.36M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $1.45M 10-Q · filed 2024-08-06 | $2.86M 10-Q · filed 2024-08-06 | ||
| 2022-12-31 | $3.82M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |